BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38600610)

  • 1. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression.
    Qiao Y; Su M; Zhao H; Liu H; Wang C; Dai X; Liu L; Liu G; Sun H; Sun M; Wang J; Li Z; Fan J; Zhang Q; Li C; Situ F; Xue J; Jia Z; Zhang C; Zhang S; Shan C
    J Exp Clin Cancer Res; 2024 Apr; 43(1):108. PubMed ID: 38600610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4.
    Wang Z; Li H; Cai H; Liang J; Jiang Y; Song F; Hou C; Hou J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Ji FH; Fu XH; Li GQ; He Q; Qiu XG
    Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.
    Lin Z; Wan AH; Sun L; Liang H; Niu Y; Deng Y; Yan S; Wang QP; Bu X; Zhang X; Hu K; Wan G; He W
    Mol Ther; 2023 Feb; 31(2):517-534. PubMed ID: 36307991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation.
    Shen LD; Qi WH; Bai JJ; Zuo CY; Bai DL; Gao WD; Zong XL; Hao TT; Ma Y; Cao GC
    Anat Rec (Hoboken); 2021 Feb; 304(2):313-322. PubMed ID: 31961485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway.
    Jiang T; Xiao Y; Zhou J; Luo Z; Yu L; Liao Q; Liu S; Qi X; Zhang H; Hou M; Miao W; Batsaikhan B; Damba T; Liang Y; Li Y; Zhou L
    Redox Biol; 2023 Dec; 68():102963. PubMed ID: 37984229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.
    Jin Z; Gao W; Guo F; Liao S; Hu M; Yu T; Yu S; Shi Q
    J Neurochem; 2023 Jul; 166(2):328-345. PubMed ID: 37300304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF2BP3 is an essential N
    Xu X; Cui J; Wang H; Ma L; Zhang X; Guo W; Xue X; Wang Y; Qiu S; Tian X; Miao Y; Wu M; Yu Y; Xu Y; Wang J; Qiao Y
    Mater Today Bio; 2022 Dec; 17():100503. PubMed ID: 36457846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting AKT induced Ferroptosis through FTO/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer.
    Zhang G; Mi W; Wang C; Li J; Zhang Y; Liu N; Jiang M; Jia G; Wang F; Yang G; Zhang L; Wang J; Fu Y; Zhang Y
    Cell Death Discov; 2023 Dec; 9(1):457. PubMed ID: 38102129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2.
    Zhang FY; Wu L; Zhang TN; Chen HH
    Commun Biol; 2024 Mar; 7(1):262. PubMed ID: 38438714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
    Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
    Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor heterogeneity in autophagy-dependent ferroptosis.
    Li J; Liu J; Xu Y; Wu R; Chen X; Song X; Zeh H; Kang R; Klionsky DJ; Wang X; Tang D
    Autophagy; 2021 Nov; 17(11):3361-3374. PubMed ID: 33404288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification.
    Ye Y; Chen A; Li L; Liang Q; Wang S; Dong Q; Fu M; Lan Z; Li Y; Liu X; Ou JS; Lu L; Yan J
    Kidney Int; 2022 Dec; 102(6):1259-1275. PubMed ID: 36063875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate enhances erastin-induced ferroptosis of lung cancer cells via modulating the ATF3/SLC7A11 pathway.
    Bi R; Hu R; Jiang L; Wen B; Jiang Z; Liu H; Mei J
    Environ Toxicol; 2024 Feb; 39(2):529-538. PubMed ID: 37341073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNA circSTIL inhibits ferroptosis in colorectal cancer via miR-431/SLC7A11 axis.
    Li Q; Li K; Guo Q; Yang T
    Environ Toxicol; 2023 May; 38(5):981-989. PubMed ID: 36840697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m
    Wang H; Chen W; Cui Y; Gong H; Li H
    J Cell Mol Med; 2023 Dec; 27(24):4118-4132. PubMed ID: 37830241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
    Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
    Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia.
    Feng S; Yuan Y; Lin Z; Li M; Ye D; Shi L; Li D; Zhao M; Meng C; He X; Wu S; Xiong F; Ye S; Yang J; Zhuang H; Hong L; Gao S
    Exp Hematol Oncol; 2024 Feb; 13(1):19. PubMed ID: 38378601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.